Proceedings of the 2019 Canadian Inflammatory Myopathy Study Symposium: Clinical Trial Readiness in Myositis.


Journal

The Journal of rheumatology
ISSN: 0315-162X
Titre abrégé: J Rheumatol
Pays: Canada
ID NLM: 7501984

Informations de publication

Date de publication:
01 10 2020
Historique:
pubmed: 17 6 2020
medline: 1 9 2021
entrez: 17 6 2020
Statut: ppublish

Résumé

The Canadian Inflammatory Myopathy Study (CIMS) is a multicenter prospective cohort recruiting in 8 centers across Canada. One of the aims of CIMS is to conduct and participate in clinical trials in autoimmune inflammatory myopathies (AIM). Conducting clinical trials in rare diseases such as AIM presents challenges. During this symposium, experts in the field presented different solutions to successfully conduct clinical trials in AIM, including the importance of collaboration and careful trial design, as well as training and mentoring of young investigators.

Identifiants

pubmed: 32541080
pii: jrheum.200480
doi: 10.3899/jrheum.200480
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1584-1586

Auteurs

Valérie Leclair (V)

V. Leclair, MD, Department of Medicine, McGill University, and Division of Rheumatology, Jewish General Hospital, Montreal, Quebec, Canada; valerie.leclair@mcgill.ca.

Océane Landon-Cardinal (O)

O. Landon-Cardinal, MD, Department of Medicine, Université de Montréal, and Division of Rheumatology and Research Center, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.

Rohit Aggarwal (R)

R. Aggarwal, MD, MSc, Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

Nick Bansback (N)

N. Bansback, PhD, University of British Columbia and Arthritis Research Canada, Vancouver, British Columbia, Canada.

Craig Campbell (C)

C. Campbell, MD, Department of Pediatrics, London Children's Hospital, University of Western Ontario, London, Ontario, Canada.

Brian M Feldman (BM)

B.M. Feldman, MD, MSc, Faculty of Medicine and IHPME Dalla Lana School of Public Health, University of Toronto, and Division of Rheumatology, The Hospital for Sick Children, Toronto, Ontario, Canada.

Martin Jarry (M)

M. Jarry, Patient Advocate, S. McNamara, PhD, B. White, MD, Corbus Pharmaceutical Holdings Inc., Norwood, Massachusetts, USA.

Suzan McNamara (S)

M. Jarry, Patient Advocate, S. McNamara, PhD, B. White, MD, Corbus Pharmaceutical Holdings Inc., Norwood, Massachusetts, USA.

Barbara White (B)

M. Jarry, Patient Advocate, S. McNamara, PhD, B. White, MD, Corbus Pharmaceutical Holdings Inc., Norwood, Massachusetts, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH